References - Therapeutic Strategies in Cancer Biology and Pathology - page 260

Yang, H.S., Matthews, C.P., Clair, T., Wang, Q., Baker, A.R., Li, C.C.H., et al., 2006.
Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase
kinase kinase 1 expression to suppress colon carcinoma cell Iinvasion. Mol. Cell Biol.
26, 1297-1306.
Yang, H.Y., Wen, Y.Y., Chen, C.H., Lozano, G., Lee, M.H., 2003b. 14-3-3σ positively regu-
lates p53 and suppresses tumor growth. Mol. Cell. Biol. 23, 7096-7107.
Yang, H.Y., Liu, H.L., Liu, G.Y., Zhu, H., Meng, Q.W., Qu, L.D., et al., 2011c. Expression and
prognostic value of ID-1 and ID3 in gastric adenocarcinoma. J. Surg. Res. 167, 258-266.
Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., et al., 2004.
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
Cell 117, 927-939.
Yang, K., Handorean, A.M., Iczkowski, K.A., 2009b. MicroRNAs 373 and 520c are downregu-
lated in prostate cancer, suppress CD44 translation and enhance invasion of prostate can-
cer cells in vitro. Int. J. Clin. Oncol. Exp. Pathol. 2, 361-369.
Yang, L., Wu, X., Wang, Y., Zhang, K., Wu, J., Yuan, Y.C., et al., 2011d. FZD7 has a critical
role in cell proliferation in triple negative breast cancer. Oncogene 30, 4437-4446.
Yang, X., Yin, J., Yu, J., Xiang, Q., Liu, Y., Tang, S., et al., 2012. miRNA-195 sensitizes human
hepatocellular carcinoma cells to 5-FU by targeting BCL-w. Oncol. Res. 27, 250-257.
Yao, J., Liang, L., Huang, S., Ding, J., Tan, N., Zhao, Y., et al., 2010. MicroRNA-30d pro-
motes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.
Hepatology 51, 846-856.
Yao, M., Wang, Y., Shen, H., Ning, W., Tang, J., Wang, X., et al., 2008. Identification of the
core promoter of STK11 gene and its transcriptional regulation by p53. Progr. Nat. Sci.
Mater. Int. 18, 273-280.
Yatabe, Y., Mitsudomi, T., Takahashi, T., 2004. Maspin expression in normal lung and non-
small-cell lung cancers: cellular property-associated expression under the control of pro-
moter DNA methylation. Oncogene 23, 4041-4049.
Yau, T.O., Leung, T.H.Y., Lam, S., Cheung, O.F., Tung, E.K.K.K., Khong, P.L., et al., 2009.
Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did
not aggravate hepatocarcinogenesis. Plos ONE 4, e6566.
Ye, K., 2007. Phosphorylation of Merlin regulates its stability and tumor suppressive activity.
Cell Adhes. Migrat. 1, 196-198.
Yeh, Y.C., Wei, W.C., Wang, Y.K., Lin, S.C., Sung, J., Tang, M.J., 2010. Transforming growth fac-
tor-beta 1 induces Smad3-dependent beta(1) integrin gene expression in epithelial-to-mesen-
chymal transition during chronic tubulointerstitial fibrosis. Am. J. Pathol. 177, 1743-1754.
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., et al., 1999. Suppression of
Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173-177.
Yeung, K.C., Rose, D.W., Dhillon, A.S., Yaros, D., Gustafsson, M., Chatterjee, D., et al., 2001.
Raf kinase inhibitor protein interacts with NF-kappa B-inducing kinase and TAK1 and
inhibits NF-kappa 13 activation. Mol. Cell Biol. 21, 7207-7217.
Yi, B., Tan, S.X., Tang, C.E., Huang, W.G., Cheng, A.L., Li, C., et al., 2009. Inactivation of
14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal car-
cinoma. J. Cell Biochem. 106, 858-866.
Yi, M., Yang, J., Chen, X., Li, J., Li, X., Wang, L., et al., 2011. RASSF1A suppresses mela-
noma development by modulating apoptosis and cell-cycle progression. J. Cell Physiol.
226, 2360-2369.
Ying, H., Shen, Y.H., Godlewski, J., Bronisz, A., Zhu, J., Comb, M.J., et al., 2003.
Signicance of 14-3-3 self-dimerization for phosphorylation-dependent target binding.
Mol. Biol. Cell 14, 4721-4733.